ABOS vs HHS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 05, 2026

ABOS

46.5
AI Score
VS
ABOS Wins

HHS

30.8
AI Score

Investment Advisor Scores

ABOS

47score
Recommendation
HOLD

HHS

31score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ABOS HHS Winner
Net Income -53.45M -811,000 HHS
Operating Income -53.70M 386,000 HHS
ROE -93.3% -4.0% HHS
ROA -46.1% -0.9% HHS
Total Assets 116.01M 91.83M ABOS
Cash 59.44M 5.58M ABOS
Current Ratio 2.47 1.54 ABOS

Relative Price Performance (Last 90 Days)

ABOS 1M: +39.5% · 3M: +47.9% HHS 1M: +88.9% · 3M: +65.5%

Current Technical Phase

ABOS

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (9.5% over 20 days), RSI 67

RSI (14): 67.4 · Price: $3.18

HHS

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (21.1% over 20 days), RSI 70

RSI (14): 70.3 · Price: $4.27

Fundamentals Snapshot

Metric ABOS HHS
Market Cap
Forward P/E -2.2 4.0
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% 0.0%
Gross Margin -263.8% 0.2%
Operating Margin 0.0% -0.1%
EPS -1.63 -0.76
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, ABOS is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.